OTCMKTS:ACUR Acura Pharmaceuticals (ACUR) Stock Price, News & Analysis → top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (From Traders Agency) (Ad) Free ACUR Stock Alerts $0.01 0.00 (0.00%) (As of 04/24/2024 ET) Add Compare Share Share Today's Range$0.01▼$0.0150-Day Range N/A52-Week Range$0.00▼$0.05VolumeN/AAverage Volume2,979 shsMarket Capitalization$663,500.00P/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartFinancialsHeadlinesSEC FilingsShort Interest Get Acura Pharmaceuticals alerts: Email Address Ad Traders Agencytop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.Click here now for the full details of this stock that’s set to rocket in the AI revolution… About Acura Pharmaceuticals Stock (OTCMKTS:ACUR)Acura Pharmaceuticals, Inc., an innovative drug delivery company, engages in the research, development, and commercialization of technologies and products to address safe use of medications in the United States. It offers Oxaydo tablets, a Schedule II narcotic indicated for the management of acute and chronic moderate to severe pain; and Nexafed products, which are pseudoephedrine and acetaminophen tablets that are used as nasal decongestants in various non-prescription and prescription cold, sinus, and allergy products. Acura Pharmaceuticals, Inc. has collaboration and license agreements with Egalet US, Inc. and Egalet Ltd. to manufacture and commercialize Oxaydo products worldwide; and development and commercialization agreement with Abuse Deterrent Pharma, LLC to develop LTX-03, an immediate-release tablets utilizing LIMITx technology. The company was formerly known as Halsey Drug Co., Inc. The company was incorporated in 1935 and is based in Palatine, Illinois. Acura Pharmaceuticals, Inc. operates as a subsidiary of Abuse Deterrent Pharma, LLC.Read More ACUR Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ACUR Stock News HeadlinesApril 20, 2024 | americanbankingnews.comAcura Pharmaceuticals (OTCMKTS:ACUR) Share Price Passes Above 200-Day Moving Average of $0.00February 28, 2024 | benzinga.comAcura Pharmaceuticals Stock (OTC:ACUR), Insider Trading ActivityApril 25, 2024 | Traders Agency (Ad)top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.February 10, 2024 | yahoo.comRobert Kraft's foundation wants people to "stand up to hate" with Super Bowl adFebruary 5, 2024 | msn.comAmerican Honda reports 10.3% Y/Y sales growth in January amid a sequential declineJanuary 13, 2024 | morningstar.comAcura Pharmaceuticals Inc ACURNovember 20, 2023 | yahoo.comCumberland man jailed in alleged death threat against district court judgeSeptember 26, 2023 | news.yahoo.comMiami man distributed over $16 million of adulterated HIV drugs given to U.S. patientsApril 25, 2024 | Traders Agency (Ad)top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.August 24, 2023 | finance.yahoo.comAcura Pharmaceuticals, Inc. (ACUR)August 12, 2023 | forbes.comAcura Extended Warranty Review: Everything You Need To KnowJune 30, 2023 | au.finance.yahoo.comACUR - Acura Pharmaceuticals, Inc.May 31, 2023 | msn.comGot $1,000? 2 Amazing Growth Stocks That Could Help You Retire RicherMay 3, 2023 | marketwatch.comExploring the Growth Potential of the Opioid Drugs Market till 2031April 27, 2023 | marketwatch.comAzilsartan Medoxomil API Market Forecast to 2030April 22, 2023 | thestreet.com4 Stocks Under $10 Moving HigherApril 9, 2023 | benzinga.comGlobal Royalty Rate Trends in Pharma and Biotech Dealmaking 2010-2023: One-Stop Source for Providing Real-Deal Information on Hundreds of TransactionsApril 9, 2023 | marketwatch.comOpioid Drugs Market Sales By 2030March 29, 2023 | marketwatch.comCalming and Sleeping Market Outlook and Forecast till 2028March 13, 2023 | thestreet.comAcura Stock Soars (ACUR)February 17, 2023 | marketwatch.comOpioid Drugs Market Forcast 2023 To 2028 : In-depth Research Analysis with Top Countries DataFebruary 13, 2023 | marketwatch.comAzilsartan Medoxomil API Market 2023-2029 Global Forecast with Top Key Players such as: Takeda, Lupin, Acura Labs, Metrochem APIFebruary 8, 2023 | marketwatch.comOpioid Drugs Market Global Demand, Opportunities, Trends, Analysis and Forecast to 2028January 25, 2023 | marketwatch.comAnalysis of Azilsartan Medoxomil API Market for the Period 2023 to 2028 : Development, Growth and Key FactorsJanuary 5, 2023 | thestreet.comPfizer, Acura Painkiller Approved by FDASeptember 4, 2022 | msn.comWoman shot in face, hand in drive-by shooting on Queens street, 2 vehicles soughtAugust 18, 2022 | marketwatch.comCalming and Sleeping Market Size and Growth 2022 Analysis Report by Manufactures, Trends, Share, Opportunity, Regions and Forecast to 2028See More Headlines Receive ACUR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Acura Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/28/2020Today4/24/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Pharmaceutical preparations Sub-IndustryPharmaceuticals Current SymbolOTCMKTS:ACUR Previous SymbolNASDAQ:ACUR CUSIP00509L70 CIK786947 Webwww.acurapharm.com Phone(847) 705-7709Fax847-705-5399Employees9Year Founded1935Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$1.56 million Price / Sales0.43 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares66,350,000Free Float52,947,000Market Cap$663,500.00 OptionableNot Optionable Beta1.89 Social Links Beginners Guide To Retirement StocksClick the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. Robert B. Jones (Age 65)CEO, President & Director Comp: $150kMr. Peter A. Clemens (Age 71)Senior VP, CFO & Secretary Comp: $200kMr. Robert A. Seiser CPA (Age 60)Ph.D., VP, Treasurer & Corporate Controller Comp: $210.2kKey CompetitorsRespireRx PharmaceuticalsOTCMKTS:RSPIBellerophon TherapeuticsNASDAQ:BLPHArgos TherapeuticsOTCMKTS:ARGSQAditxtNASDAQ:ADTXEvelo BiosciencesNASDAQ:EVLOView All Competitors ACUR Stock Analysis - Frequently Asked Questions How have ACUR shares performed in 2024? Acura Pharmaceuticals' stock was trading at $0.0001 at the start of the year. Since then, ACUR shares have increased by 9,900.0% and is now trading at $0.01. View the best growth stocks for 2024 here. How were Acura Pharmaceuticals' earnings last quarter? Acura Pharmaceuticals, Inc. (OTCMKTS:ACUR) issued its quarterly earnings data on Friday, February, 28th. The specialty pharmaceutical company reported $0.00 EPS for the quarter. The specialty pharmaceutical company had revenue of $1.32 million for the quarter. What other stocks do shareholders of Acura Pharmaceuticals own? Based on aggregate information from My MarketBeat watchlists, some companies that other Acura Pharmaceuticals investors own include Denali Therapeutics (DNLI), Adamis Pharmaceuticals (ADMP), Ekso Bionics (EKSO), VIVUS (VVUS), Fulcrum Therapeutics (FULC), (GBSN) (GBSN), Trevena (TRVN), AcelRx Pharmaceuticals (ACRX), Allena Pharmaceuticals (ALNA) and Advanced Micro Devices (AMD). How do I buy shares of Acura Pharmaceuticals? Shares of ACUR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. Does Acura Pharmaceuticals have any subsidiaries? The following companies are subsidiares of Acura Pharmaceuticals: Acura Pharmaceutical Technologies Inc..Read More This page (OTCMKTS:ACUR) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyFed launches fourth dollar overhaulStansberry Research1970’s computer coder issues shocking A.I. warningTradeSmithExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersNew Trump BombshellThe Freeport SocietyMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acura Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
